News

John H. Sampson, MD, PhD, was formerly inducted into the National Academy of Medicine at the annual meeting on October 13, 2018, in Washington, D.C.

Duke researchers, including Peter Fecci, MD, have received grants to further study brain metastasis.

In an article published in the journal Nature on September 26, 2018 ("Immunotherapy Offers a Promising Bet Against Brain Cancer,") Duke Neurosurgery Chair John H. Sampson, MD, PhD, provides commentary on the promise of  the therapy to treat glioblastoma, the deadliest form of brain cancer.

Duke Neurosurgery is a proud sponsor of a screening of the  highly acclaimed film, Becoming Johanna. This powerful film follows a transgender Latina from 16 to 21 years of a

Duke Neurosurgery continues to improve in quality, ranking near the top of its peer group, according to data supplied by Vizient, a national company that measures performance for health care organizations.

Duke Neurosurgery’s focus on wellness among faculty and staff has meant that more and more in the department are taking up running.

Congratulations to Duke Neurosurgery residents Alexa Bramall, MD,PhD and Shervin Rahimpour, MD, who were named  2018-2019 Feagin Leadership Scholars.

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

When Duke neurosurgeon Michael Haglund, MD, PhD, took his first humanitariam trip to Uganda 12 years ago, he says he "saw the need, and it was beyond great."

Scott E. Page, PhD, director of the Center for the Study of Complex Systems at the University of Michigan, will present the Allan H. Friedman Lecture on August 29, 2018.